Author:
Frey Melissa K.,Dao Fanny,Olvera Narciso,Konner Jason A.,Dickler Maura N.,Levine Douglas A.
Subject
Obstetrics and Gynaecology,Oncology
Reference40 articles.
1. Bevacizumab;Ellis;Nat. Rev. Drug Discov.,2005
2. Improved survival with bevacizumab in advanced cervical cancer;Tewari;N. Engl. J. Med.,2014
3. Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: the AURELIA open-label randomized phase III trial;Pujade-Lauraine;J. Clin. Oncol.,2014
4. OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer;Aghajanian;J. Clin. Oncol.,2012
5. Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer;Aghajanian;Gynecol. Oncol.,2015
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献